Skip to main content
SpringerLink
Log in

225-actinium-PSMA

Various toxicities : 5 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Satapathy S, et al. Health-related quality-of-life outcomes with actinium-225-prostate-specific membrane antigen-617 therapy in patients with heavily pretreated metastatic castration-resistant prostate cancer. Indian Journal of Nuclear Medicine 35: 299-304, No. 4, Dec 2020. Available from: URL: http://doi.org/10.4103/ijnm.IJNM_130_20

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

225-actinium-PSMA. Reactions Weekly 1865, 17 (2021). https://doi.org/10.1007/s40278-021-99305-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-99305-5

Search

Navigation